IP Library Granted Patent US 10,881,347
Granted Patent B2
US 10,881,347 · App. 15/927,769 · Granted Jan 5, 2021

Closed loop dialysis treatment using adaptive ultrafiltration rates

Inventors: Louis L. Barrett (West Point, UT); Ken Chhi (Fremont, CA); David Yuds (Hudson, NH); Tom Merics (Antioch, CA); Joan Dowd (Concord, CA)
Assignee: Fresenius Medical Care Holdings, Inc.
A61B5/4836A61B5/0295A61B5/14535A61B5/6866A61M1/1603A61M1/3403A61B5/14542
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,881,347
App. No.
15/927,769
Granted
Jan 5, 2021
Kind
B2
Abstract

A method of performing closed-loop dialysis treatment during hemodialysis is provided. The method involves determining an initial ultrafiltration rate and setting an ultrafiltration pump of a dialysis system to the determined ultrafiltration rate. A series of measurements and calculations are made to ensure that a rate of change of blood volume during treatment follows a specified profile. A threshold may be used to keep the rate of change of blood volume tracking the profile. Patient fluid dynamics may be measured in real-time and used to determine the ultrafiltration pump rate.

Claims (52)

1. A method for performing closed loop dialysis treatment comprising:

(a) determining an ultrafiltration rate;

(b) setting an ultrafiltration pump to the determined ultrafiltration rate for an active duration;

(c) measuring a total change in blood volume;

(d) setting the ultrafiltration pump to a minimum pump rate for a rebound duration;

(e) measuring a rebound change in blood volume;

repeating steps (b)-(e) a first number of times to obtain a regression set, the regression set comprising a number of pairwise values, wherein each pairwise value is a measurement of the total change in blood volume and a measurement of the rebound change in blood volume;

(f) updating the ultrafiltration rate using the regression set;

(g) updating the regression set by repeating steps (b)-(e); and

repeating steps (f) and (g) a second number of times, wherein a total duration of one plus the first number of times and one plus the second number of times is a treatment period.

2. The method according to claim 1 , wherein repeating steps (b)-(e) the first number of times to obtain the regression set comprises:

repeating steps (b)-(e) two times to obtain the regression set.

3. The method according to claim 1 , wherein step (a) comprises determining the ultrafiltration rate from:

a total fluid volume to be removed during the dialysis treatment;

a past patient treatment tolerance;

lab measurements;

physical examinations; and/or

weight at time of presenting for dialysis.

4. The method according to claim 1 , wherein step (a) comprises determining that the ultrafiltration rate is an initial ultrafiltration rate multiplied by a factor based on an amount of time that the ultrafiltration is expected to be at the minimum pump rate during the treatment period.

5. The method according to claim 1 , wherein the treatment period is 3 hours, the rebound duration is 5 minutes, and the active duration is 15 minutes.

6. The method according to claim 1 , wherein step (f) comprises:

regressing the pairwise values in the regression set to obtain a polynomial;

solving for an expected rebound change in blood volume at the end of the treatment period based on the polynomial; and

updating the ultrafiltration rate based on the expected rebound change in blood volume at the end of the treatment period.

7. The method according to claim 1 , wherein step (g) further comprises updating the regression set by dropping a least recent pairwise value from the regression set.

8. A method for performing closed loop dialysis treatment comprising:

(a) determining an ultrafiltration rate;

(b) setting an ultrafiltration pump to the determined ultrafiltration rate for an active duration;

(c) measuring a total change in blood volume during the active duration to determine when a blood volume waypoint is met;

(d) setting the ultrafiltration pump to a minimum pump rate for a rebound duration;

(e) measuring a rebound change in blood volume for the rebound duration;

(f) updating the blood volume waypoint;

repeating steps (b)-(f) a first number of times to obtain a regression set, the regression set comprising a number of pairwise values, wherein each pairwise value is a measurement of the total change in blood volume and a measurement of the rebound change in blood volume;

(g) determining a dry weight time to meet a dry weight goal using the regression set; and

(h) determining whether the treatment period is adequate to reaching the dry weight goal.

9. The method according to claim 8 , further comprising:

based on the treatment period being adequate to reaching the dry weight goal, dropping a least recent pairwise value in the regression set;

updating the regression set by repeating steps (b)-(f); and

repeating steps (g) and (h).

10. The method according to claim 8 , further comprising:

based on the treatment period not being adequate to reaching the dry weight goal, stopping the closed loop dialysis treatment.

11. The method according to claim 8 , further comprising:

based on the treatment period not being adequate to reaching the dry weight goal, dropping a least recent pairwise value in the regression set;

adjusting the ultrafiltration rate;

updating the regression set by repeating steps (b)-(f); and

repeating steps (g) and (h).

12. The method according to claim 8 , wherein determining the dry weight time to meet the dry weight goal using the regression set comprises:

regressing the pairwise values in the regression set to obtain a polynomial;

solving for an expected rebound change in blood volume at the end of the treatment period based on the polynomial; and

updating the dry weight time based on the expected rebound change in blood volume at the end of the treatment period.

13. The method according to claim 8 , wherein the treatment period is 3 hours and the rebound duration is 5 minutes.

14. The method according to claim 8 , wherein updating the blood volume waypoint comprises increasing the blood volume waypoint by a fixed percentage.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 8, 2018
From: BARRETT, LOUIS L.; CHHI, KEN; YUDS, DAVID; MERICS, TOM; DOWD, JOAN
To: FRESENIUS MEDICAL CARE HOLDINGS, INC.
Reel/Frame 046101/0545 →
Continuity (2)
Provisional Application 62612037 · Dec 29, 2017
Related Publication 20190200921A1 · Jul 4, 2019
Cited By (5)
US 12,239,459 US 12,280,007 US 12,357,734 US 12,415,021 US 12,508,351